DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2478896
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2478896
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Oct 10, 2024 | Depomed Inc | NUCYNTA ER | tapentadol hydrochloride |
➤ Sign Up | Aug 8, 2024 | Endo Pharms | OPANA ER | oxymorphone hydrochloride |
➤ Sign Up | Nov 20, 2023 | Depomed Inc | NUCYNTA ER | tapentadol hydrochloride |
➤ Sign Up | Nov 20, 2023 | Endo Pharms | OPANA ER | oxymorphone hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |